Dermatol. praxi. 2016;10(1):16-19 | DOI: 10.36290/der.2016.004

Trends in treating perioral dermatitis

MUDr. Hana Duchková, DrSc.
Kožní sanatorium, s. r. o. Ústí nad Labem

In the treatment of perioral dermatitis, local treatment is preferred (antibiotics, metronidazole, azelaic acid, pimecrolimus, tacrolimus). Systemic treatment with antibiotics, isotretinoin, or short-term pulse corticosteroids is recommended when there is failure of local treatment. "Zero therapy" refers to withdrawal of local agents, drugs and cosmetics. Topical corticosteroids are contraindicated in perioral dermatitis.

Keywords: perioral dermatitis, etiology, treatment

Published: April 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Duchková H. Trends in treating perioral dermatitis. Dermatol. praxi. 2016;10(1):16-19. doi: 10.36290/der.2016.004.
Download citation

References

  1. Hafeez ZH. Perioral dermatitis: an update. Int J Dermatol 2003; 42: 514-517. Go to original source...
  2. Dirschka T, Tronnier H. Periokuläre dermatitis. J Dtsch Dermatol Ges 2004; 2: 274-278. Go to original source...
  3. Nguyen V, Eichenfield LE. Periorificial dermatitis in children and adolescents, J. Am Acad Dermatol 2006; 55: 781-785. Go to original source... Go to PubMed...
  4. Hall CS, Reichenberg I. Evidence based review of perioral dermatitis therapy. Gital.dermatol.venereol. 2010; 145: 433-444.
  5. Wolenberg A, et al. Perioral dermatitis. Guideline. JDDG. 5. 2011; 422-428. Go to original source...
  6. Dirschka T, Szliska C, Jackowski J, Tronnier H. Impaired skin barrier and atopic diathesis in perioral diathesis. Dtsch Dermatol Ges 2003; 1: 199-203. Go to original source...
  7. Dirschka T, Weber K, Tronnier H. Topical cosmetics and perioral dermatitis. J Dtsch Dermatol Ges 2004; 194-199. Go to original source...
  8. Weber K, Thurmayr R. A topical erytromycin preparation and oral tetracykline for the treatment of perioral dermatitis a placebo-controlled trial. J Dermatol Treat. 1993; 4: 57-59. Go to original source...
  9. Kumar P, et al. Perioral dermatitis in a child associated with an inhalation steroid. Dermatol Online J. 2010; 13. Go to original source...
  10. Wollenberg A, Oppel T. Scoring of skin lesions with the Perioral Dermatitis. Severity Index. Acta Dermatol Venereol 2006; 86: 254-255. Go to original source... Go to PubMed...
  11. Oppel T, Pavicic T, et al. Pimecrolimus cream (1) efficacy in perioral dermatitis - results of a randomized, double blind, vehicle controlled study in 40 patients. J Eur Acad Dermatol Venereol 2007; 21: 1175-1180. Go to original source...
  12. Jansen T. GrabbeS. Perioral dermatitis in childhood - Clinical features, etiopathogenesis and treatment with special reference to own experiences with the use of 20% azelaic acid cream. Aktualle Dermatologie 2007; 33: 190-193.
  13. Ishiguro N, Maeda A, Suzuki K. Three cases of perioral dermatitis related to fusobacteria treated with beta-lactam antibiotik. J Dermatol. 1994; 25: 507-509. Go to original source...
  14. Smitt JH Das PK, Van Gingel JW. Granulomatous perioral dermatitis Br J Dermatol 1991; 125: 399.
  15. Kolbe I, et al. Corticoid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001; 7: 73-77. Go to original source... Go to PubMed...
  16. Miller SR, Shalita AR. Topical metronidazole gel (0,75% for the treatment of perioral dermatitis in children). J Am Acad Dermatol. 1994; 31: 847-848. Go to original source...
  17. Veien NK, Munkvad JM, NielsonAO, et al. Topical metronidazole in the treatment of perioral dermatitis. J Am Acad. Dermatol 1999; 24: 258-326. Go to original source...
  18. Tempark T, Shvayder TA. Perioral Dermatitis: A Review of the Condition with Special Attention to Treatment Options. Am J. Dermatol. 2014; 15: 100-115. Go to original source... Go to PubMed...
  19. Reichenberg J. Perioralis (periorificial) dermatitis.www.uptodate.com. 2015. Literature review current through: Aug 2015, last uptodate Jun. 16, 2015.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.